1. Home
  2. MLEC vs IRD Comparison

MLEC vs IRD Comparison

Compare MLEC & IRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLEC
  • IRD
  • Stock Information
  • Founded
  • MLEC 2008
  • IRD 2018
  • Country
  • MLEC Luxembourg
  • IRD United States
  • Employees
  • MLEC N/A
  • IRD 14
  • Industry
  • MLEC Blank Checks
  • IRD
  • Sector
  • MLEC Finance
  • IRD
  • Exchange
  • MLEC Nasdaq
  • IRD NYSE
  • Market Cap
  • MLEC 23.9M
  • IRD 36.0M
  • IPO Year
  • MLEC N/A
  • IRD N/A
  • Fundamental
  • Price
  • MLEC $0.55
  • IRD $1.16
  • Analyst Decision
  • MLEC
  • IRD Strong Buy
  • Analyst Count
  • MLEC 0
  • IRD 1
  • Target Price
  • MLEC N/A
  • IRD $8.00
  • AVG Volume (30 Days)
  • MLEC 7.8K
  • IRD 147.6K
  • Earning Date
  • MLEC 03-12-2025
  • IRD 02-19-2025
  • Dividend Yield
  • MLEC N/A
  • IRD N/A
  • EPS Growth
  • MLEC N/A
  • IRD N/A
  • EPS
  • MLEC N/A
  • IRD N/A
  • Revenue
  • MLEC $5,625,124.00
  • IRD $8,381,000.00
  • Revenue This Year
  • MLEC $20.42
  • IRD N/A
  • Revenue Next Year
  • MLEC $30.00
  • IRD $29.37
  • P/E Ratio
  • MLEC N/A
  • IRD N/A
  • Revenue Growth
  • MLEC 521.53
  • IRD N/A
  • 52 Week Low
  • MLEC $0.55
  • IRD $0.81
  • 52 Week High
  • MLEC $3.25
  • IRD $2.77
  • Technical
  • Relative Strength Index (RSI)
  • MLEC 34.92
  • IRD N/A
  • Support Level
  • MLEC $0.71
  • IRD N/A
  • Resistance Level
  • MLEC $0.78
  • IRD N/A
  • Average True Range (ATR)
  • MLEC 0.03
  • IRD 0.00
  • MACD
  • MLEC -0.01
  • IRD 0.00
  • Stochastic Oscillator
  • MLEC 0.00
  • IRD 0.00

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

Share on Social Networks: